Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-1977

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use ; volume:35 ; number:9 ; day:18 ; month:7 ; year:2019 ; pages:459 ; date:9.2019
Drugs & therapy perspectives ; 35, Heft 9 (18.7.2019), 459, 9.2019

Creator: Blair, Hannah A.
Lyseng-Williamson, Katherine A.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40267-019-00654-4

URN: urn:nbn:de:101:1-2019123107283821384860

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Blair, Hannah A.
Lyseng-Williamson, Katherine A.
SpringerLink (Online service)

Other Objects (12)

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura

Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

Prognostic factors in thrombotic thrombocytopenic purpura

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study

Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura

Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

$A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura$

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura

Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

Prognostic factors in thrombotic thrombocytopenic purpura

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study

Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura

Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

$A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura$

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura

Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

Prognostic factors in thrombotic thrombocytopenic purpura

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study

Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura

Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

$A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura$

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura

Thrombotic thrombocytopenic purpura

Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

Prognostic factors in thrombotic thrombocytopenic purpura

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study

Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura

Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura

Thrombotic thrombocytopenic purpura

Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

Prognostic factors in thrombotic thrombocytopenic purpura

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study

Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura

Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura

Thrombotic thrombocytopenic purpura

Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

Prognostic factors in thrombotic thrombocytopenic purpura

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study

Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura

Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

Related objects

Reset password